MEDEA Biopharma
Biotechnology Research
Ludwigshafen Am Rhein, Rhineland-palatinate, De
10 employees
- Employees
- 10
- Contacts
- 1
- Emails
- 1
MEDEA Biopharma Overview
- Headquarters
- Ludwigshafen Am Rhein, Rhineland-palatinate, De
- Website
- www.medea-bio.com
- Industry
- Biotechnology Research
- Employees
- 10
- Founded
- 2023
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About MEDEA Biopharma
Medea Biopharma GmbH, a German biotech company based in Ludwigshafen, Germany, was co-founded by Rüdiger Trojok, Dr. Elene Kakabadze, and Giorgi Khubua. Medea Biopharma GmbH specializes in the development of a new generation of sustainable and eco-friendly antibacterial solutions based on bacteriophages (phages), designed to solve the global crisis of antimicrobial resistance. Phages are natural bacterial killers, which are highly specific and without side effects. These innovative alternatives aim to replace conventional chemical antibiotics, copper-based solutions, and harmful pesticides, offering effective and environmentally responsible ways to combat harmful bacteria across diverse sectors, including human health, animal well-being, and agriculture.
MEDEA Biopharma Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
MEDEA Biopharma Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Brian Segebrecht | Animal Health Executive | Salt Lake City, Utah, United States |
Email
|
| Michael Plank | Head of R&D - Medea Biopharma Gmbh | Regenstauf, Bavaria, Germany |
View
|
| Racha Benarrait | Chercheuse & Doctorante En Ingénierie | Brunswick, Lower Saxony, Germany |
View
|
Employees by Management Level
Individual contributor
2 profiles
VP / Head
1 profile
Compare Similar Companies to MEDEA Biopharma
PhageLab
Biotechnology Research
Eligo Bioscience
Biotechnology Research
Phagos
Biotechnology Research
Zamann Pharma Support
Business Consulting And Services
Caesar.
Venture Capital And Private Equity Principals
Tolka AI Therapeutics
Biotechnology Research
Merall Bioproducts GmbH
Farming
Onmatter
Construction
Phage Australia
Biotechnology Research
Streavent
Events Services